Rigel Pharma (RIGL) Tops Q2 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 51.29 +2.43 (4.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.86 | 52 Week High | $4.38 | |||
| Open | $50.57 | 52 Week Low | $1.88 | |||
| Day High | $51.74 | P/E | N/A | |||
| Day Low | $49.23 | EPS | $-1.12 | |||
| Volume | 288,611 | |||||
